179 related articles for article (PubMed ID: 26935541)
1. Comparative study of antitumor effects of bromelain and papain in human cholangiocarcinoma cell lines.
Müller A; Barat S; Chen X; Bui KC; Bozko P; Malek NP; Plentz RR
Int J Oncol; 2016 May; 48(5):2025-34. PubMed ID: 26935541
[TBL] [Abstract][Full Text] [Related]
2. Metformin Exerts Antiproliferative and Anti-metastatic Effects Against Cholangiocarcinoma Cells by Targeting STAT3 and NF-ĸB.
Saengboonmee C; Seubwai W; Cha'on U; Sawanyawisuth K; Wongkham S; Wongkham C
Anticancer Res; 2017 Jan; 37(1):115-123. PubMed ID: 28011481
[TBL] [Abstract][Full Text] [Related]
3. FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling.
Lu Z; Wang J; Zheng T; Liang Y; Yin D; Song R; Pei T; Pan S; Jiang H; Liu L
BMC Cancer; 2014 Oct; 14():783. PubMed ID: 25344679
[TBL] [Abstract][Full Text] [Related]
4. Metformin enhances cisplatin induced inhibition of cholangiocarcinoma cells via AMPK-mTOR pathway.
Wandee J; Prawan A; Senggunprai L; Kongpetch S; Tusskorn O; Kukongviriyapan V
Life Sci; 2018 Aug; 207():172-183. PubMed ID: 29847773
[TBL] [Abstract][Full Text] [Related]
5. Bromelain inhibits nuclear factor kappa-B translocation, driving human epidermoid carcinoma A431 and melanoma A375 cells through G(2)/M arrest to apoptosis.
Bhui K; Tyagi S; Srivastava AK; Singh M; Roy P; Singh R; Shukla Y
Mol Carcinog; 2012 Mar; 51(3):231-43. PubMed ID: 21432909
[TBL] [Abstract][Full Text] [Related]
6. Abnormal expression of Forkhead Box J2 (FOXJ2) suppresses migration and invasion in extrahepatic cholangiocarcinoma and is associated with prognosis.
Qiang Y; Wang F; Yan S; Zhang H; Zhu L; Chen Z; Tu F; Wang D; Wang G; Wang W; Chen Z
Int J Oncol; 2015; 46(6):2449-58. PubMed ID: 25873280
[TBL] [Abstract][Full Text] [Related]
7. Role of cantharidin in the activation of IKKα/IκBα/NF‑κB pathway by inhibiting PP2A activity in cholangiocarcinoma cell lines.
Zhou H; Xu J; Wang S; Peng J
Mol Med Rep; 2018 Jun; 17(6):7672-7682. PubMed ID: 29620225
[TBL] [Abstract][Full Text] [Related]
8. Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells.
Dokduang H; Yongvanit P; Namwat N; Pairojkul C; Sangkhamanon S; Yageta MS; Murakami Y; Loilome W
Oncol Rep; 2016 Apr; 35(4):2065-72. PubMed ID: 26794001
[TBL] [Abstract][Full Text] [Related]
9. The H4 histamine receptor agonist, clobenpropit, suppresses human cholangiocarcinoma progression by disruption of epithelial mesenchymal transition and tumor metastasis.
Meng F; Han Y; Staloch D; Francis T; Stokes A; Francis H
Hepatology; 2011 Nov; 54(5):1718-28. PubMed ID: 21793031
[TBL] [Abstract][Full Text] [Related]
10. Mycoepoxydiene induces apoptosis and inhibits TPA-induced invasion in human cholangiocarcinoma cells via blocking NF-κB pathway.
Li W; Li M; Su X; Qin L; Miao M; Yu C; Shen Y; Luo Q; Chen Q
Biochimie; 2014 Jun; 101():183-91. PubMed ID: 24486723
[TBL] [Abstract][Full Text] [Related]
11. Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma.
Hu MH; Huang TT; Chao TI; Chen LJ; Chen YL; Tsai MH; Liu CY; Kao JH; Chen KF
Liver Int; 2018 Dec; 38(12):2248-2259. PubMed ID: 29797403
[TBL] [Abstract][Full Text] [Related]
12. Anticancer effect of bromelain with and without cisplatin or 5-FU on malignant peritoneal mesothelioma cells.
Pillai K; Ehteda A; Akhter J; Chua TC; Morris DL
Anticancer Drugs; 2014 Feb; 25(2):150-60. PubMed ID: 24366282
[TBL] [Abstract][Full Text] [Related]
13. Cratoxylum formosum Extracts Inhibit Growth and Metastasis of Cholangiocarcinoma Cells by Modulating the NF-κB and STAT3 Pathways.
Senggunprai L; Thammaniwit W; Kukongviriyapan V; Prawan A; Kaewseejan N; Siriamornpun S
Nutr Cancer; 2016; 68(2):328-41. PubMed ID: 26908056
[TBL] [Abstract][Full Text] [Related]
14. SVCT-2 determines the sensitivity to ascorbate-induced cell death in cholangiocarcinoma cell lines and patient derived xenografts.
Wang C; Lv H; Yang W; Li T; Fang T; Lv G; Han Q; Dong L; Jiang T; Jiang B; Yang G; Wang H
Cancer Lett; 2017 Jul; 398():1-11. PubMed ID: 28385602
[TBL] [Abstract][Full Text] [Related]
15. UCP2 regulates cholangiocarcinoma cell plasticity via mitochondria-to-AMPK signals.
Yu J; Shi L; Shen X; Zhao Y
Biochem Pharmacol; 2019 Aug; 166():174-184. PubMed ID: 31085159
[TBL] [Abstract][Full Text] [Related]
16. Capsaicin treatment attenuates cholangiocarcinoma carcinogenesis.
Wutka A; Palagani V; Barat S; Chen X; El Khatib M; Götze J; Belahmer H; Zender S; Bozko P; Malek NP; Plentz RR
PLoS One; 2014; 9(4):e95605. PubMed ID: 24748170
[TBL] [Abstract][Full Text] [Related]
17. Corilagin suppresses cholangiocarcinoma progression through Notch signaling pathway in vitro and in vivo.
Gu Y; Xiao L; Ming Y; Zheng Z; Li W
Int J Oncol; 2016 May; 48(5):1868-76. PubMed ID: 26935808
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial activity of papain and bromelain on Alicyclobacillus spp.
dos Anjos MM; da Silva AA; de Pascoli IC; Mikcha JM; Machinski M; Peralta RM; de Abreu Filho BA
Int J Food Microbiol; 2016 Jan; 216():121-6. PubMed ID: 26476327
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma.
Xu YF; Yang XQ; Lu XF; Guo S; Liu Y; Iqbal M; Ning SL; Yang H; Suo N; Chen YX
Biochem Biophys Res Commun; 2014 Mar; 446(1):54-60. PubMed ID: 24565842
[TBL] [Abstract][Full Text] [Related]
20. Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis
Padthaisong S; Thanee M; Techasen A; Namwat N; Yongvanit P; Liwatthakun A; Hankla K; Sangkhamanon S; Loilome W
Anticancer Res; 2017 Jul; 37(7):3591-3597. PubMed ID: 28668850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
